³Ô¹ÏÍøÕ¾

Latest pre-clinical News | Page 2

Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune
Clarity’s theranostic prostate cancer trial progresses at the highest dose level cohort
Bacteria and stomach cancer: breaking link
New therapy target to shut down multiple myeloma’s ability to survive and thrive
Medical science a ‘priority area’ for new Industry Growth Program
Cracking the code: researchers unravel how mutant protein drives cancer growth
How to protect newborn brain
Turning back clock on brains aged by Covid
Growth restricted babies and asphyxia – cardiovascular impacts
Mater Researchers discover double layer of protection to help gut health
Groundbreaking gene therapy trial for Hunter syndrome opens
Imugene announces phase 1 clinical trial opens with onCARlytics CD19 virus technology
Support For Victorian Medical Research Powers On
Dietary supplement modifies gut microbiome
New view of gene therapy
Fibre boost could combat ‘chemo brain’ drain
WHO recommends R21/Matrix-M vaccine for malaria prevention in updated advice on immunization
Tiny fish could be key to develop treatment against MND
Ultrathin nanotech promises to help tackle antibiotic resistance
New discovery: dual acting drug delivers blood cancer a lethal ‘one-two’ punch
Can the body’s signalling protein be harnessed to stop ovarian cancer?
Australian vaccine breakthrough offers hope against EBV-associated cancers and MS
Universal siRNA Covid treatment shows promise in lab
Funding for research into repairing a damaged heart
Kangaroos could help injured athletes get back in game
Pharmaxis reports positive analysis of data from phase 2 PXS-5505 study
International collaboration to fund breakthrough research to shape the future of precision medicine
Cure Brain Cancer Foundation Unveils Fellowship Awardees
Neuren opens first site in US for Prader-Willi syndrome Phase 2 trial
Monash awarded more than $18M for critical infrastructure to advance medical and health research
Breakthrough drug could treat long COVID and prevent re-infection
Fast Five with Safiya Naina Marikar
Top performing ASX life science companies
Major development for cancer-killing ‘Masterswitch’ discovery
Benefits of creatine: safer birth for mum and baby
CUREator funds Hudson Institute biotech innovation
CAR-NKT cell therapy shows promising results against neuroblastoma in phase 1 clinical trial
Advanced immunotherapy treatment may hold promise for children with brain cancer
$77 million for research into cardiovascular health, dementia and aged care and stem cell therapies
Wonder drug-capsule may one day replace insulin injection for diabetics
Proto Axiom invests in University of Sydney spin-out, EndoAxiom
Spin-off developing oral insulin receives commercial backing
Are you missing out on super benefits of chia seeds?
PCFA Research “Holy Grail”: Stopping metastatic prostate cancer cells spreading undetected
Using tiny brains to treat rare, hereditary diseases
Significant step in fight against drug resistance in TB
New therapy gives important flu treatment option
Preventing brain damage in preterm babies